EN
HI
Summary
As of 29 Aug, 2026, Alivus Life Sciences stock price is ₹1350.2. During the trading session, the stock has moved between an intraday low of ₹1338.20 and an intraday high of ₹1375.90. Over the last 52 weeks, Alivus Life Sciences has traded between ₹819.00 and ₹1418.00.
The stock has recorded a trading volume of 51,812 shares, with a market capitalization of ₹122739448. Its Average Traded Price (ATP) is ₹1350.75, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 21 @ ₹1350.20.
Alivus Life Sciences has an upper circuit limit of ₹1620.20 and a lower circuit limit of ₹1080.20. The total value traded stands at ₹7.00 CR, and the delivery percentage for the day is 54.22%.
The stock is currently traded with a market lot size of 1. Alivus Life Sciences also offers a dividend yield of 0%.
Alivus Life Sciences share price chart
Alivus Life Sciences Share Key Metrics
Volume
51812.00
Market Cap
16572.28 CR
LTQ@LTP
21@1350.20
ATP
1350.75
Var Margin
16.71 %
Circuit Range
1080.2-1620.2
Delivery %
54.22 %
Value
7.00 CR
ASM/GSM
No
Market Lot
1
Alivus Life Sciences Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.1
Sector P/B
3.41
Sec. Div. Yield
0.51
Alivus Life Sciences Resistance and Support
Pivot 1370.43
Resistance
First Resistance
1387.76
Second Resistance
1417.33
Third Resistance
1434.66
Support
First Support
1340.86
Second Support
1323.53
Third Support
1293.96
Alivus Life Sciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 1358.2 | 1350.2 | -0.59% | 1375.9 | 1338.2 |
| Thu Aug 27 2026 | 1362.9 | 1358.19 | -0.19% | 1400 | 1353.09 |
| Wed Aug 26 2026 | 1344.8 | 1360.8 | 0.92% | 1371.3 | 1334 |
Alivus Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-14 | Audited Results & Final Dividend |
| 2026-01-22 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-24 | Quarterly Results |
Alivus Life Sciences News
Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Alivus Life Sciences is scheduled to hold investor and analyst meetings on August 18 and 19, 2026. These one-on-one sessions will be with Green Lantern Capital, SIMPL, Burman Capital, and Karma Capital, both in-person and virtually.
Aug 13 2026 11:56:44
Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Alivus Life Sciences will host an in-person investor/analyst meet on August 12, 2026. The meeting at Emkay Confluence, Mumbai, will include both group and one-on-one sessions for investors and analysts.
Aug 07 2026 12:29:19
Read More
Alivus Life Sciences Management
| Name | Position |
|---|---|
| Rudalf Corriea | Company Secretary & Compliance Officer |
| Hiren K Patel | Chairman |
Alivus Life Sciences Similar Stocks
Rainbow Children's Medicare Ltd.
1442.80
1.80 (0.12%)
Molbio Diagnostics Ltd.
1094.75
-49.40 (4.32%)
Jubilant Pharmova Ltd.
882.65
3.95 (0.45%)
CORONA Remedies Ltd.
2079.50
-3.70 (0.18%)
Sudeep Pharma Ltd.
1152.10
18.00 (1.59%)
Park Medi World Ltd.
290.55
0.40 (0.14%)
Akums Drugs & Pharmaceuticals Ltd.
772.60
11.40 (1.50%)
Metropolis Healthcare Ltd.
588.45
11.55 (2.00%)
Viyash Scientific Ltd.
267.40
7.90 (3.04%)
Sanofi Consumer Healthcare India Ltd.
4213.70
63.70 (1.53%)
Alivus Life Sciences FAQs
The Buying Price of Alivus Life Sciences share is 1350.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alivus Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alivus Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alivus Life Sciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alivus Life Sciences shares is 0. Useful to assess the stock's value relative to its book value.
To assess Alivus Life Sciences’s valuation compare Sector P/E, P/B which are 69.1 & 3.41 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alivus Life Sciences is 16572.28 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alivus Life Sciences share price is 1418.00 & 819.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alivus Life Sciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
